LUNG in the 13F filings
Pulmonx Corp · CUSIP 745848101
- Quarter end
- 31 Dec 2023
- the date the book describes
- Filed
- 14 Feb 2024
- latest of these filings; the earliest 14 Feb 2024
- Managers listing it
- 2
- at least, of 95 tracked, among listed positions
- Comparable managers
- 93
- filed both Q3 2023 and Q4 2023; 2 listed it in both
- Shares listed
- 1,577,686
- combined, among listed positions
- Reported value
- $20m
- combined, at the quarter end
Among the 93 comparable managers: 1 buyer (opened or added shares) and 2 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -1,514,978.
Managers listing LUNG in Q4 2023
2 of 2 holders
| Action | Filing | |||||
|---|---|---|---|---|---|---|
| Point72 Asset Management LP | 1,546,089 | $20m | under 0.1% | Trimmed | -1,383,814 | 14 Feb 2024 (the filing on sec.gov) |
| PDT Partners LLC | 31,597 | $403k | under 0.1% | Added | +36 | 14 Feb 2024 (the filing on sec.gov) |
Largest increases and reductions, by shares
Increases
- PDT Partners LLCexisting position · 31,597 shares now+36
Reductions
- Point72 Asset Management LPexisting position · 1,546,089 shares now-1,383,814
New positions and exits
New (0)
No new position among listed positions.
Exited (1)
- Woodline Partners LPwas $1.4m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q4 2020 | 5 | $81m | n.a. | n.a. |
| Q1 2021 | 5 | $73m | n.a. | n.a. |
| Q2 2021 | 5 | $163m | n.a. | n.a. |
| Q3 2021 | 5 | $123m | n.a. | n.a. |
| Q4 2021 | 3 | $107m | n.a. | n.a. |
| Q1 2022 | 3 | $88m | n.a. | n.a. |
| Q2 2022 | 3 | $8.1m | n.a. | n.a. |
| Q3 2022 | 3 | $11m | n.a. | n.a. |
| Q4 2022 | 3 | $22m | n.a. | n.a. |
| Q1 2023 | 3 | $44m | n.a. | n.a. |
| Q2 2023 | 3 | $47m | n.a. | n.a. |
| Q3 2023 | 3 | $32m | n.a. | n.a. |
| Q4 2023 | 2 | $20m | 1 | 2 |
| Q1 2024 | 2 | $26m | 2 | 0 |
| Q2 2024 | 1 | $446k | 0 | 0 |
| Q3 2024 | 1 | $730k | 1 | 0 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
LUNG and LLY →LUNG and JNJ →LUNG and VRTX →Choose a stock to compare with LUNG →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own LUNG, latest filings →Back to the 13F Explorer →